UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study

PLoS medicine, 2022-02, Vol.19 (2), p.e1003904-e1003904

2022

Link zum Volltext

Verfügbarkeit prüfen

Increasing representation and diversity in cardiovascular clinical trial populations

Nature reviews cardiology, 2021-08, Vol.18 (8), p.537-538

2021

Link zum Volltext

Verfügbarkeit prüfen

Applications of digital technology in COVID-19 pandemic planning and response

The Lancet. Digital health, 2020-08, Vol.2 (8), p.e435-e440

2020

Link zum Volltext

Verfügbarkeit prüfen

Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials

BMC medicine, 2022-09, Vol.20 (1), p.1-294, Article 294

2022

Link zum Volltext

Verfügbarkeit prüfen

Location of death among patients presenting with cardiovascular disease to the emergency department in the United states

International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e13798-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Variations in stepped-wedge cluster randomized trial design: Insights from the Patient-Centered Care Transitions in Heart Failure trial

The American heart journal, 2020-02, Vol.220, p.116-126

2020

Link zum Volltext

Verfügbarkeit prüfen

Urban–rural disparities in diabetes-related mortality in the USA 1999–2019

Diabetologia, 2022-12, Vol.65 (12), p.2078-2083

2022

Link zum Volltext

Verfügbarkeit prüfen

Interventions to enhance digital health equity in cardiovascular care

Nature medicine, 2024-03, Vol.30 (3), p.628-630

2024

Link zum Volltext

Verfügbarkeit prüfen

Pregnant and lactating women should be included in clinical trials for cardiovascular disease

Nature medicine, 2023-08, Vol.29 (8), p.1897-1899

2023

Link zum Volltext

Verfügbarkeit prüfen

Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials

BMJ (Online), 2013-02, Vol.346 (7899), p.f657

International edition, 2013

Link zum Volltext

Verfügbarkeit prüfen

The collateral damage of COVID-19 to cardiovascular services: a meta-analysis

European heart journal, 2022-09, Vol.43 (33), p.3164-3178

2022

Link zum Volltext

Verfügbarkeit prüfen

Can we stop reflexively discontinuing mineralocorticoid antagonists for patients with heart failure and hyperkalemia?

Journal of cardiac failure, 2022-09, Vol.28 (9), p.1464-1468

2022

Link zum Volltext

Verfügbarkeit prüfen

Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey

Diabetologia, 2022-09, Vol.65 (9), p.1461-1472

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of an Interactive Digital Health-Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases: A Randomized Clinical Trial

JAMA network open, 2021-12, Vol.4 (12), p.e2140591-e2140591

2021

Link zum Volltext

Verfügbarkeit prüfen

Bias: does it account for low surgical rates in women with infective endocarditis?

Heart (British Cardiac Society), 2021-11, Vol.107 (21), p.1688

2021

Link zum Volltext

Verfügbarkeit prüfen

In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status

Annals of internal medicine, 2022-10, Vol.175 (10), p.JC111

2022

Link zum Volltext

Verfügbarkeit prüfen

The need for increased pragmatism in cardiovascular clinical trials

Nature reviews cardiology, 2022-11, Vol.19 (11), p.737-750

2022

Link zum Volltext

Verfügbarkeit prüfen

Regional variations in heart failure: a global perspective

Heart (British Cardiac Society), 2024-01, Vol.110 (1), p.11

2024

Link zum Volltext

Verfügbarkeit prüfen

Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study

European heart journal, 2022-06, Vol.43 (24), p.2289-2299

2022

Link zum Volltext

Verfügbarkeit prüfen

Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies

Journal of clinical epidemiology, 2023-08, Vol.160, p.1-13

2023

Link zum Volltext

Verfügbarkeit prüfen

Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries: An Analysis of Patients Receiving Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Circulation (New York, N.Y.), 2012-11, Vol.126 (19), p.2309-2316

2012

Link zum Volltext

Verfügbarkeit prüfen

Enrollment of Black, Indigenous, and Other People of Color in Multicountry Randomized Controlled Trials of Diabetes Conducted in North America and Europe

Diabetes care, 2022-07, Vol.45 (7), p.e116-e117

2022

Link zum Volltext

Verfügbarkeit prüfen

Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF

Annals of internal medicine, 2020-09, Vol.173 (6), p.JC30

2020

Link zum Volltext

Verfügbarkeit prüfen

In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months

Annals of internal medicine, 2019-03, Vol.170 (6), p.JC28

Van Spall, Harriette G C

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(170)

Sprache

Englisch
(170)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(142)
Cardiovascular System & Cardiology
(109)
Cardiac & Cardiovascular Systems
(108)
Humans
(96)
Heart Failure
(66)
Female
(34)
Male
(33)
Mortality
(24)
Heart Failure - Therapy
(22)
Aged
(21)
General & Internal Medicine
(21)
Hospitalization
(21)
Medicine, General & Internal
(21)
Patients
(19)
Cardiovascular Disease
(18)
Clinical Trials
(18)
Diabetes
(16)
Risk Factors
(16)
Middle Aged
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study

Increasing representation and diversity in cardiovascular clinical trial populations

Applications of digital technology in COVID-19 pandemic planning and response

Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials

Location of death among patients presenting with cardiovascular disease to the emergency department in the United states

Variations in stepped-wedge cluster randomized trial design: Insights from the Patient-Centered Care Transitions in Heart Failure trial

Urban–rural disparities in diabetes-related mortality in the USA 1999–2019

Interventions to enhance digital health equity in cardiovascular care

Pregnant and lactating women should be included in clinical trials for cardiovascular disease

Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials

The collateral damage of COVID-19 to cardiovascular services: a meta-analysis

Can we stop reflexively discontinuing mineralocorticoid antagonists for patients with heart failure and hyperkalemia?

Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey

Assessment of an Interactive Digital Health-Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases: A Randomized Clinical Trial

Bias: does it account for low surgical rates in women with infective endocarditis?

In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status

The need for increased pragmatism in cardiovascular clinical trials

Regional variations in heart failure: a global perspective

Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study

Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies

Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries: An Analysis of Patients Receiving Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender

Enrollment of Black, Indigenous, and Other People of Color in Multicountry Randomized Controlled Trials of Diabetes Conducted in North America and Europe

Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF

In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months

Suchergebnisse filtern